HEXAL AG

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 22233
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 3137
 
  
 
C07K PEPTIDES 3133
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
2404 MATERIALS FOR DRESSING WOUNDS, NURSING AND MEDICAL CARE323
 
  
 
A61L METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES 269
 
  
 
B65B MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING 262
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153
 
  
 
B05B SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES 163
 
  
 
B32B LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM1156

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0067,124 METHOD OF MAPPING GLYCANS OF GLYCOPROTEINSSep 08, 17Mar 08, 18[G01N]
2018/0042,861 TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING BUPRENORPHRINEOct 26, 17Feb 15, 18[A61K]
2017/0254,791 METHOD AND DEVICE FOR DETERMINING THE DISINTEGRATION TIME OF FILM-SHAPED PHARMACEUTICAL DOSAGE FORMSAug 05, 15Sep 07, 17[G01N]
2017/0205,423 Method of Mapping Glycans of Glycoproteins in Serum SamplesJul 17, 15Jul 20, 17[G01N]
2016/0151,484 METHODS AND FORMULATIONS WHICH ALLOW THE MODULATION OF IMMUNE RESPONSES RELATED TO THE ADMINISTRATION OF A BIOPHARMACEUTICAL DRUGJul 21, 14Jun 02, 16[A61K, C07K]
2016/0129,113 TABLETS COMPRISING A TASTE MASKING AGENTDec 14, 15May 12, 16[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9895497 Method for reducing leachables and extractables in syringesMay 13, 14Feb 20, 18[A61M, B65B]
9844515 Transdermal therapeutic system comprising buprenorphineNov 17, 11Dec 19, 17[A61K, A61F]
9789112 Oral pharmaceutical film formulation for bitter tasting drugsJun 10, 16Oct 17, 17[A61K]
9717707 Pharmaceutical statin compositionDec 06, 12Aug 01, 17[A61K]
9592296 Pharmaceutical composition for oral administration with a statinAug 21, 12Mar 14, 17[A61K]
9480743 Pharmaceutical formulation comprising a biopharmaceutical drugDec 28, 11Nov 01, 16[A61K, C07K]
9211265 Tablets comprising a taste masking agentApr 12, 10Dec 15, 15[A61K]
8785431 Prodrugs of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systemsJun 20, 12Jul 22, 14[A61K, C07D]
8720165 Method for reducing leachables and extractables in syringesMay 20, 09May 13, 14[B65B]
8722090 Granulate comprising an oily substance, corresponding production method and tabletDec 11, 03May 13, 14[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0333,424 Amorphous Vortioxetine HydrobromideAbandonedOct 23, 15Nov 23, 17[A61K]
2016/0199,293 METHOD FOR MANUFACTURING AN INGESTIBLE FILM, APPARATUS FOR MANUFACTURING AN INGESTIBLE FILM, INGESTIBLE FILM AND PHARMACEUTICAL DOSAGE FORM COMPRISING THE SAMEAbandonedOct 02, 14Jul 14, 16[A61K]
2016/0018,409 IMPROVED METHOD OF MAPPING GLYCANS OF GLYCOPROTEINSAbandonedOct 17, 13Jan 21, 16[G01N]
2015/0366,807 ORAL PHARMACEUTICAL COMPOSITION COMPRISING DABIGATRAN ETEXILATEAbandonedDec 04, 13Dec 24, 15[A61K]
2015/0283,067 ORODISPERSIBLE FILM COMPOSITIONSAbandonedNov 13, 13Oct 08, 15[A61K]
2014/0363,516 MULTIPLE UNIT PELLET TABLET FORMULATION COMPRISING AN OPIOIDAbandonedDec 18, 12Dec 11, 14[A61K]
2013/0216,594 PREPARATION OF ORODISPERSIBLE FILMSAbandonedOct 27, 11Aug 22, 13[A61K]
2013/0217,697 ORAL PHARMACEUTICAL FILM FORMULATION FOR BITTER TASTING DRUGSAbandonedOct 27, 11Aug 22, 13[A61K]
8501056 Homogenized product for implants and microparticlesExpiredMay 23, 02Aug 06, 13[B05B]
2012/0149,713 ORAL FILMS COMPRISING 7-[4-[4-(2,3-DICHLOROPHENYL) PIPERAZIN-1-L]BUTOXY]-3,4-DIHYDRO-1H-QUINOLIN-2-ONE BASE OR SALTS OR HYDRATES THEREOFAbandonedMar 25, 10Jun 14, 12[A61K, C07D]
2012/0082,721 Enteric coatingAbandonedMay 28, 10Apr 05, 12[A61K, B05D]
2010/0140,131 Production of an Oxaliplatin Mixture and a Container and a Container Set for Said MixtureAbandonedAug 11, 06Jun 10, 10[A61K, A61P, B65D]
2009/0186,341 Receptacle for the Separation of Tumor CellsAbandonedFeb 20, 06Jul 23, 09[C12Q, B01L]
2009/0162,420 Matrix-Controlled Transdermal System Comprising Salts of ACE Inhibitor Dicarboxylic AcidsAbandonedDec 05, 06Jun 25, 09[A61K, C07F, C07D]
2009/0082,596 Process for the Preparation of AdamantanaminesAbandonedFeb 20, 07Mar 26, 09[C07C]
2008/0279,915 Matrix-Controlled Transdermal Therapeutic System Based on an Adhesive for Administering Norelgestromin or the Combination Thereof with an EstrogenAbandonedJun 09, 05Nov 13, 08[A61K, A61P]
2008/0254,112 Pharmaceutical Active-Ingredient-Containing Formulation with CoatingAbandonedOct 28, 04Oct 16, 08[A61K]
2008/0217,202 Cycloolefin Copolymer Bottle with a Scratch-Resistant CoatingAbandonedJul 26, 06Sep 11, 08[B65D]
2008/0213,343 Oral, Quickly Disintegrating Film, which Cannot be Spit Out, for an Antiemetic or Antimigraine AgentAbandonedJul 20, 06Sep 04, 08[A61K, A61P]
2008/0208,141 Plastic Bottle for Oxaliplatin SolutionAbandonedDec 28, 05Aug 28, 08[A61B, A61M]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.